Tenet Healthcare Q2 Outlook: Revenue $4.9B-$5.1B Vs. $4.98B Estimate, Adj. EPS $1.58-$1.98 Vs. $1.41 Estimate, GAAP EPS $1.49-$1.93 Vs. $1.38 Estimate
Portfolio Pulse from Benzinga Newsdesk
Tenet Healthcare (THC) provided its Q2 and full year 2024 outlook, projecting revenues between $4.9B-$5.1B for Q2, surpassing the $4.98B estimate. Adjusted EPS for Q2 is expected to be between $1.58-$1.98, exceeding the $1.41 estimate. The full year 2024 outlook includes net operating revenues of $20,000 to $20,400 million and adjusted EBITDA of $3,500 to $3,700 million. These projections follow the sale of nine hospitals in South Carolina and California.
April 30, 2024 | 10:50 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Tenet Healthcare's Q2 and full year 2024 financial outlook exceeds analyst estimates, with higher projected revenues and adjusted EPS. The completion of the sale of nine hospitals is expected to positively influence these figures.
The positive outlook provided by Tenet Healthcare, especially with revenues and EPS exceeding estimates, is likely to instill confidence in investors. The completion of significant asset sales adds to the positive momentum, potentially leading to a short-term uptick in THC's stock price.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100